cell in Medical Technology
Navigation Links
cell in Medical Technology
... indicate that KRAS plays an important role in cell growth regulation. In mCRC, EGFR transmits ... the nucleus, these signals instruct the cancer cell to reproduce and metastasize, leading to cancer ... sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of ...
... The initial focus will be on pancreatic beta cell regeneration and survival, to restore beta cell function in diabetes. The program builds on ... at GNF that has resulted in the discovery of beta cell regeneration drug targets and candidates, and ...
... MDS is a heterogeneous group of blood stem cell disorders of increasing incidence. MDS is characterized by ineffective blood cell production involving one or more of the red cell, white cell or platelet lineages and with MDS patients having ...
... SEATTLE, Aug. 3 /PRNewswire-FirstCall/ -- cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) ... that in patients with advanced non-small cell lung cancer (NSCLC), the combination of OPAXIO ... compared to standard therapies. About cell Therapeutics, Inc. Headquartered in Seattle, ...
... from their peripheral blood and mixed with a cell culture of the patient's own melanoma cells that ... months, p=.016). Eight patients in the dendritic cell vaccine study experienced remarkable long-term, ... patient-specific biological treatments in its cell biology laboratory, and provides a wealth of ...
... the largest and most established leaders in stem cell innovation today announced a research and ... global regenerative technology leader and stem cell research company. The partnership will allow ... a global leader in regenerative medicine and stem cell R&D, to explore the utilization and potential ...
... SEATTLE, July 21 /PRNewswire-FirstCall/ -- cell Therapeutics (CTI) (Nasdaq and MTA: CTIC) ... the NCI research indicates that the tumor cell DNA damaging effects of brostallicin are enhanced ... was active in a trabectedin-resistant cell line. "These preclinical data provide ...
... that a study of the gene regulation in multiple cell lines by several of their estrogen receptor beta ... hormone therapy. The study also demonstrates the cell type selectivity of Menerba (MF101) and ... of Bionovo's ERb selective drugs, in different cell types. These compelling findings will serve as a ...
... reovirus and chemotherapy against human non-small cell lung cancer (NSCLC). The paper, entitled ... Reovirus and Chemotherapeutic Agents in Non-Small cell Lung Cancer Cells" appears online in the July 14, ... significant multiple drug resistance in certain cell lines," said Dr. Brad Thompson, President and CEO ...
... which are pathways associated with programmed cell death, cell growth, cell differentiation ...
... (treatment naive) patients with Squamous cell Carcinoma of the Head and Neck. Early ... primary Head and Neck cancer (Oral Squamous cell Carcinoma) during the impending Multikine Pivotal ... to utilize to launch aseptic filling for stem cell produced therapies and other biological products. ...
... member of the Roche Group, for the generation of cell lines with novel characteristics for ... genes in a Chinese hamster ovary (CHO) cell line. The milestone achievement triggered a ... protein production to streamline the process of cell line production, increase the yield and improve ...
... neuron replacement program at California Stem cell and UCI. These three programs represent an ... Neuron Replacement Program: California Stem cell (CSC) is preparing for a final FDA pre-IND ... for the use of these cells in development of a cell replacement therapy for SMA Type I. Numerous ...
... of the trial protocol. "This is the largest cell therapy dose ranging trial ever undertaken in the ... promising results over a four-fold range of cell concentrations administered weekly. This ... both keratinocytes and fibroblasts, the two major cell types found in human skin. Using a unique ...
... reported through week 104 included basal cell skin cancer (one patient), colon cancer (one patient) and small cell lung cancer (one patient) in patients receiving SIMPONI 50 mg, and basal cell skin cancer (three patients), prostate cancer ...
... orBec(R) conducted at 16 leading bone marrow/stem cell transplantation centers in the US and France. ... cancer patients after receiving hematopoietic cell transplantation. Unlike organ transplants where ... life-threatening complication of hematopoietic cell transplantation. DOR expects to begin a ...
... the immune system, such as DLBCL, mantle cell lymphoma and follicular lymphoma(2). Up to 60% of ... Hodgkin's disease, follicular lymphoma, mantle cell lymphoma, DLBCL and small lymphocytic lymphoma; ... (53% ORR), follicular lymphoma (50% ORR), mantle cell lymphoma (32% ORR), DLBCL (30% ORR) and small ...
... Stem cell Technologies for Surgery TEXARKANA, Texas, ... /PRNewswire/ -- A new breakthrough in adult stem cell technology has three Texarkana neurosurgeons ... adoption to benefit all patients in need of cell therapy. "As a neurosurgeon, I pride myself ...
... ORLANDO, Fla., June 3 /PRNewswire-FirstCall/ -- cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) ... to 2.0, OPAXIO increases tumor specific radiation cell kill by a factor of 7.2 to 8.4 -fold (Milas Luka ... locally advanced adenocarcinoma or squamous cell carcinoma of the esophagus or gastro-esophageal ...
... Myeloma Program, Bone Marrow and Blood Stem cell Transplantation at St. Vincent's Comprehensive ... and dexamethasone during the "Lymphoma and Plasma cell Disorders" poster session. "In spite of ... prior treatment with all approved agents and stem cell transplant." Sustained Clinical Benefit in ...
... which are pathways associated with programmed cell death, cell growth, cell differentiation ...
... were hematologic, including anemia (low red blood cell count), neutropenia (low white blood cell count) and thrombocytopenia (low blood platelet ... (Stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible. ...
... which are pathways associated with programmed cell death, cell growth, cell differentiation ...
... according to disease type, including non-small cell lung cancer, small cell lung cancer, ovarian cancer and renal cancer. ... responses observed in renal cancer and small cell lung cancer patients. A total of 55 patients ...
... the Phase III ZODIAC study in advanced non-small cell lung cancer patients, with the investigational ... rash, diarrhea and neutropenia (low white blood cell count) (ZODIAC). Incidence of protocol-defined ... prostate cancer combined(4). Non-small cell lung cancer accounts for around 85% of all lung ...
... is designed to inhibit both angiogenesis and cell proliferation by targeting and binding to ... transduction and are important in controlling cell growth/angiogenesis, differentiation, ... AKT and mTOR is also known to promote tumor cell survival, proliferation, and growth. ...
... for cancer, as a treatment for advanced renal cell carcinoma. Abstract #5034, entitled, "Phase II study of perifosine in metastatic renal cell carcinoma (RCC) progressing after prior therapy ... to patients with 2nd or 3rd line metastatic renal cell cancer. We are grateful to Dr. Vogelzang, Dr. ...
... TKI258 (dovitinib lactate) in metastatic renal cell carcinoma (mRCC) patients refractory to approved ... study of heavily pre-treated metastatic renal cell carcinoma patients demonstrated that TKI258 500 ... of HSP90, a key target that regulates tumor cell survival and division, through the use of AUY922, ...
... Small Molecule Stem cell Modulator Administered in Dual Cord Blood ... clinical trial of FT1050, a small molecule Stem cell Modulator (SCM) designed to increase hematopoietic stem cell (HSC) number and function through its activation ...
... fixatives are developed to both preserve cell morphology and fix the state of cellular ... analysis. LCM is used to isolate specific cell populations from many different types of cells ... subsequent molecular assays is specific to that cell population. RPMA enables sensitive, quantitative, ...
... The initial focus will be on pancreatic beta cell regeneration and survival, to restore beta cell function in diabetes. The program builds on ... at GNF that has resulted in the discovery of beta cell regeneration drug targets and candidates, and ...
... MDS is a heterogeneous group of blood stem cell disorders of increasing incidence. MDS is characterized by ineffective blood cell production involving one or more of the red cell, white cell or platelet lineages and with MDS patients having ...
... SEATTLE, Aug. 3 /PRNewswire-FirstCall/ -- cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) ... that in patients with advanced non-small cell lung cancer (NSCLC), the combination of OPAXIO ... compared to standard therapies. About cell Therapeutics, Inc. Headquartered in Seattle, ...
... from their peripheral blood and mixed with a cell culture of the patient's own melanoma cells that ... months, p=.016). Eight patients in the dendritic cell vaccine study experienced remarkable long-term, ... patient-specific biological treatments in its cell biology laboratory, and provides a wealth of ...
... the largest and most established leaders in stem cell innovation today announced a research and ... global regenerative technology leader and stem cell research company. The partnership will allow ... a global leader in regenerative medicine and stem cell R&D, to explore the utilization and potential ...
Injection Reverses Heart-Attack Damage
... heart defects. In the July 24 issue of cell , they show that a growth factor called ... cells (cardiomyocytes) normally withdraw from the cell cycle - meaning they stop dividing and ... at Children's, were able to restart the cell cycle with NRG1, stimulating cardiomyocytes to ...... SEATTLE, July 21 /PRNewswire-FirstCall/ -- cell Therapeutics (CTI) (Nasdaq and MTA: CTIC) ... the NCI research indicates that the tumor cell DNA damaging effects of brostallicin are enhanced ... was active in a trabectedin-resistant cell line. "These preclinical data provide ...
... that a study of the gene regulation in multiple cell lines by several of their estrogen receptor beta ... hormone therapy. The study also demonstrates the cell type selectivity of Menerba (MF101) and ... of Bionovo's ERb selective drugs, in different cell types. These compelling findings will serve as a ...
... reovirus and chemotherapy against human non-small cell lung cancer (NSCLC). The paper, entitled ... Reovirus and Chemotherapeutic Agents in Non-Small cell Lung Cancer Cells" appears online in the July 14, ... significant multiple drug resistance in certain cell lines," said Dr. Brad Thompson, President and CEO ...
Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
... due to the impermeability of B. cepacia's cell envelope. In addition, B. cepacia - just like ... rescue mechanisms that pump tobramycin out of the cell are inhibited by the fusion process. The ... maximum release of tobramycin into the bacterial cell together with inhibition of the clearance ...... which are pathways associated with programmed cell death, cell growth, cell differentiation ...
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... is a patented formulation of Mycobacterial cell Wall-DNA Complex (MCC) developed by Bioniche for ... is a formulation of MCC, a sterile mycobacterial cell wall-DNA complex composition that has a dual mode ... to the development of Bioniche's mycobacterial cell wall technologies by means of a C$9.6 million ...... (treatment naive) patients with Squamous cell Carcinoma of the Head and Neck. Early ... primary Head and Neck cancer (Oral Squamous cell Carcinoma) during the impending Multikine Pivotal ... to utilize to launch aseptic filling for stem cell produced therapies and other biological products. ...
Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy
... clinical trials (MARVEL) to advance muscle stem cell (myoblast) therapy for treating heart failure to ... of Medicine, discussed the difficulties of stem cell therapy in scar tissue. "Cells of the myoblast ... therapy is at this time point the only stem cell therapy that is making the claim to actually ...... member of the Roche Group, for the generation of cell lines with novel characteristics for ... genes in a Chinese hamster ovary (CHO) cell line. The milestone achievement triggered a ... protein production to streamline the process of cell line production, increase the yield and improve ...
Alfacell Provides Shareholder Update
... genes, we added Onconase to three mesothelioma cell lines at a dose which is achievable in humans, ... in all of these genes in the mesothelioma cell lines were seen after treatment with Onconase ... to chemotherapy. Moreover, these data in cell lines are complemented by most recent animal ...... neuron replacement program at California Stem cell and UCI. These three programs represent an ... Neuron Replacement Program: California Stem cell (CSC) is preparing for a final FDA pre-IND ... for the use of these cells in development of a cell replacement therapy for SMA Type I. Numerous ...
... of the trial protocol. "This is the largest cell therapy dose ranging trial ever undertaken in the ... promising results over a four-fold range of cell concentrations administered weekly. This ... both keratinocytes and fibroblasts, the two major cell types found in human skin. Using a unique ...
UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
... Cancer Institute (UPCI) and the Gamida cell - Teva Joint Venture announced today that the ... clinical director of UPCI's Hematopoietic Stem cell Transplant Program. "Using umbilical cord blood ... 10th in funding from the NCI. About Gamida cell ...... reported through week 104 included basal cell skin cancer (one patient), colon cancer (one patient) and small cell lung cancer (one patient) in patients receiving SIMPONI 50 mg, and basal cell skin cancer (three patients), prostate cancer ...
ThermoGenesis Announces National Institute of Health Grant
... FIRST-EVER NIH GRANT WILL BE USED TO DEVELOP cell DELIVERY TECHNOLOGIES FOR REGENERATIVE MEDICINE ... The study will be conducted at the Company's stem cell research laboratory and through a collaboration ... Officer of ThermoGenesis. "We will be using stem cell concentrates prepared by our AXP(TM) AutoXpress ...... orBec(R) conducted at 16 leading bone marrow/stem cell transplantation centers in the US and France. ... cancer patients after receiving hematopoietic cell transplantation. Unlike organ transplants where ... life-threatening complication of hematopoietic cell transplantation. DOR expects to begin a ...
Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
... of autoimmune type 1 diabetes, will preserve beta cell function as measured by c-peptide, a surrogate measure of beta cell function. The primary endpoint will be a measurement of C-peptide, a surrogate measure of beta cell function. For information about DEFEND, please ...... the immune system, such as DLBCL, mantle cell lymphoma and follicular lymphoma(2). Up to 60% of ... Hodgkin's disease, follicular lymphoma, mantle cell lymphoma, DLBCL and small lymphocytic lymphoma; ... (53% ORR), follicular lymphoma (50% ORR), mantle cell lymphoma (32% ORR), DLBCL (30% ORR) and small ...
... Stem cell Technologies for Surgery TEXARKANA, Texas, ... /PRNewswire/ -- A new breakthrough in adult stem cell technology has three Texarkana neurosurgeons ... adoption to benefit all patients in need of cell therapy. "As a neurosurgeon, I pride myself ...
... ORLANDO, Fla., June 3 /PRNewswire-FirstCall/ -- cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) ... to 2.0, OPAXIO increases tumor specific radiation cell kill by a factor of 7.2 to 8.4 -fold (Milas Luka ... locally advanced adenocarcinoma or squamous cell carcinoma of the esophagus or gastro-esophageal ...
... Myeloma Program, Bone Marrow and Blood Stem cell Transplantation at St. Vincent's Comprehensive ... and dexamethasone during the "Lymphoma and Plasma cell Disorders" poster session. "In spite of ... prior treatment with all approved agents and stem cell transplant." Sustained Clinical Benefit in ...
... which are pathways associated with programmed cell death, cell growth, cell differentiation ...
... were hematologic, including anemia (low red blood cell count), neutropenia (low white blood cell count) and thrombocytopenia (low blood platelet ... (Stage IV or cancer that has spread) non-small cell lung cancer for whom surgery is not possible. ...
... which are pathways associated with programmed cell death, cell growth, cell differentiation ...
... according to disease type, including non-small cell lung cancer, small cell lung cancer, ovarian cancer and renal cancer. ... responses observed in renal cancer and small cell lung cancer patients. A total of 55 patients ...
... the Phase III ZODIAC study in advanced non-small cell lung cancer patients, with the investigational ... rash, diarrhea and neutropenia (low white blood cell count) (ZODIAC). Incidence of protocol-defined ... prostate cancer combined(4). Non-small cell lung cancer accounts for around 85% of all lung ...
... is designed to inhibit both angiogenesis and cell proliferation by targeting and binding to ... transduction and are important in controlling cell growth/angiogenesis, differentiation, ... AKT and mTOR is also known to promote tumor cell survival, proliferation, and growth. ...
Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
... data from the Phase II, open-label study in renal cell carcinoma (RCC) demonstrated a 27 percent partial ... untreated patients with predominantly clear cell RCC. BAY 73-4506 (160 mg) was administered once ... studies to prevent the proliferation of tumor cell lines while promoting apoptosis (cell death) by ...... for cancer, as a treatment for advanced renal cell carcinoma. Abstract #5034, entitled, "Phase II study of perifosine in metastatic renal cell carcinoma (RCC) progressing after prior therapy ... to patients with 2nd or 3rd line metastatic renal cell cancer. We are grateful to Dr. Vogelzang, Dr. ...
... TKI258 (dovitinib lactate) in metastatic renal cell carcinoma (mRCC) patients refractory to approved ... study of heavily pre-treated metastatic renal cell carcinoma patients demonstrated that TKI258 500 ... of HSP90, a key target that regulates tumor cell survival and division, through the use of AUY922, ...
... Small Molecule Stem cell Modulator Administered in Dual Cord Blood ... clinical trial of FT1050, a small molecule Stem cell Modulator (SCM) designed to increase hematopoietic stem cell (HSC) number and function through its activation ...
... fixatives are developed to both preserve cell morphology and fix the state of cellular ... analysis. LCM is used to isolate specific cell populations from many different types of cells ... subsequent molecular assays is specific to that cell population. RPMA enables sensitive, quantitative, ...
Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
... (T) in patients with relapsed or refractory small cell lung cancer (SCLC) after prior platinum ... #8582; Poster Board #S11; Lymphoma and Plasma cell Disorders, May 30, 8:00 a.m.-12:00 p.m. ... advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC). Abstract #e13502; ...Other ContentsaspirinaspirinaspirinaspirinchildrenchildrenchildrenchildrenchildrenchildrenchildrenchildrenchildrenastigmatismastigmatismasymptomaticasymptomaticasymptomaticasymptomaticataxiaataxiaataxiaatelectasisOther TagsROMROMROMROMROMROMROMROMROMNutritioNutritioIPUIPUIPUToysOther Tagspupils 2constant 2constant 3constant 4constant 5constant 6constant 7constant 8constant 9constant 10focuses 2focuses 3focuses 4focuses 5focuses 6focuses 7left 2left 3left 4left 5left 6left 7left 8left 9left 10should 2should 3should 4should 5should 6should 7should 8should 9should 10reefs 2reefs 3address 2address 3address 4address 5address 6address 7address 8address 9
(Date:12/1/2009)... Antennas aren,t just for listening to the radio a...s to GPS devices. Research from North Carolina Sta...nna design creating shape-shifting antennas that ...ing from public safety to military deployment. , ...als, but there are limitations to how far they can...
(Date:11/30/2009)...hose extra helpings of gravy and dessert at the ho...ine than previously thought. According to a new re...SEB Journal ( http://www.fasebj.org ), a diet tha... genes that ultimately cause our bodies to store t... double-whammy as the already difficult task of co...
(Date:11/30/2009)...This release is available in German . , The...aborative Research Centres as of 1 January 2010. T...nts Committee in Bonn. The new centres will initia...illion. In addition, 20 percent overhead funding f...roject. The centres, research topics range from mo...
Breaking Biology News(10 mins):Shape shifters: Researchers create new breed of antennas 2Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9Physiological response may explain why some severely obese patients overeat 48353 1Physiological response may explain why some severely obese patients overeat 48353 2Hypertension among lower status employees lingers well into retirement 8771 1Hypertension among lower status employees lingers well into retirement 8771 2Hypertension among lower status employees lingers well into retirement 8771 3Alzheimers and Even Mild Dementia Hasten Death 48350 1Alzheimers and Even Mild Dementia Hasten Death 48350 2(Date:12/2/2009)...k of breast cancer are well-informed about the ris...evention, only 6 percent said they were likely to ...igan Comprehensive Cancer Center created a decisio... benefits associated with tamoxifen, a drug that w... and has recently been shown to prevent breast can...
(Date:12/2/2009)...of low-income mothers who participated in a recent... general feeling of distrust of the opposite sex. ... prevent them from entering into a marriage, live-...on was often later described by some of the women ...istrust and insecurity. The results of the study a...
(Date:12/2/2009)...ook by its cover, but they now can tell the condit...S, Analytical Chemistry , a semi-monthly journal,...measure the degradation of old books and precious ...destructive "sniff" test could help libraries and ...ects, some of which are degrading rapidly due to a...
(Date:12/2/2009)...in Board: CSBR), a U.S. Oncology drug development ...ed at accelerating the development and enhancing t...lusive licensing agreement with Ramot at Tel Aviv ...d technology transfer company. , The licensing ...alization of TAR-1, a single-chain antibody fragme...
(Date:12/2/2009)...eading vendor of Internet-based chronic disease ma... of its software offering. The new release now in...weight management capabilities in addition to the ... Acton, MA. (PRWEB) December 2, 2...net-based chronic disease management software, has...
Breaking Medicine News(10 mins):Health News:High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study finds 2Health News:Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2[0] High-risk women reluctant to take tamoxifen to prevent breast cancer, U-M study finds[0] Distrust of men doesn't stall low-income mothers' romantic unions[0] 'Smell of old books' offers clues to help preserve them[0] Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug[0] MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |